Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 04 04:00PM ET
0.2419
Dollar change
-0.0145
Percentage change
-5.66
%
Index- P/E- EPS (ttm)-1.64 Insider Own21.63% Shs Outstand21.17M Perf Week-2.06%
Market Cap5.30M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float17.15M Perf Month-27.57%
Income-26.30M PEG- EPS next Q- Inst Own0.47% Short Float4.20% Perf Quarter-49.29%
Sales0.90M P/S5.88 EPS this Y- Inst Trans-3.16% Short Ratio0.40 Perf Half Y-77.81%
Book/sh0.15 P/B1.58 EPS next Y- ROA- Short Interest0.72M Perf Year-91.80%
Cash/sh0.32 P/C0.75 EPS next 5Y- ROE- 52W Range0.19 - 3.39 Perf YTD-79.15%
Dividend Est.- P/FCF- EPS past 5Y- ROI-595.61% 52W High-92.87% Beta0.06
Dividend TTM- Quick Ratio0.91 Sales past 5Y25.92% Gross Margin-72.83% 52W Low30.62% ATR (14)0.04
Dividend Ex-Date- Current Ratio0.97 EPS Y/Y TTM11.95% Oper. Margin-2975.47% RSI (14)41.83 Volatility11.82% 14.92%
Employees- Debt/Eq1.96 Sales Y/Y TTM- Profit Margin-2936.50% Recom1.00 Target Price4.00
Option/ShortNo / Yes LT Debt/Eq0.36 EPS Q/Q-1124.50% Payout- Rel Volume1.42 Prev Close0.26
Sales Surprise- EPS Surprise- Sales Q/Q- EarningsApr 09 BMO Avg Volume1.82M Price0.24
SMA20-10.08% SMA50-24.93% SMA200-66.27% Trades Volume2,578,099 Change-5.66%
Date Action Analyst Rating Change Price Target Change
Nov-21-23Downgrade Cantor Fitzgerald Overweight → Neutral
Jun-21-22Initiated H.C. Wainwright Buy $25
Oct-01-24 02:11PM
08:01AM
Sep-20-24 10:48AM
Sep-18-24 08:01AM
Sep-04-24 04:01AM
12:09PM Loading…
Jul-30-24 12:09PM
Jul-25-24 08:01AM
Jul-19-24 12:38PM
Jul-10-24 04:12AM
Jul-09-24 07:39AM
03:01AM
Jul-02-24 01:38PM
08:01AM
Jun-04-24 01:45PM
Jun-03-24 08:01AM
05:01PM Loading…
May-31-24 05:01PM
May-29-24 07:39AM
May-28-24 08:01AM
May-20-24 08:01AM
May-17-24 07:23AM
May-16-24 10:51AM
May-07-24 08:01AM
Apr-29-24 12:02PM
Apr-25-24 09:29AM
Apr-10-24 12:47PM
Apr-09-24 09:53PM
08:01AM
Mar-19-24 08:01AM
Mar-18-24 08:01AM
Mar-12-24 08:01AM
12:00PM Loading…
Mar-08-24 12:00PM
Mar-05-24 08:01AM
Feb-28-24 12:54PM
Feb-27-24 08:01AM
Feb-22-24 02:21PM
08:01AM
Feb-21-24 08:01AM
Feb-07-24 12:13PM
Feb-06-24 08:01AM
Feb-01-24 04:17PM
Jan-11-24 08:01AM
Jan-09-24 03:40PM
08:01AM
Dec-29-23 02:48PM
Dec-19-23 08:01AM
Dec-12-23 08:01AM
Dec-05-23 02:06PM
09:01AM
Nov-29-23 08:01AM
Nov-20-23 08:01AM
Nov-16-23 08:01AM
Nov-15-23 09:01AM
Nov-13-23 09:00AM
Nov-09-23 08:01AM
Nov-07-23 08:01AM
Nov-01-23 08:40AM
Oct-31-23 08:01AM
Oct-26-23 08:01AM
Oct-18-23 08:01AM
Oct-17-23 03:16PM
Oct-11-23 08:01AM
Oct-10-23 03:53PM
Oct-05-23 08:01AM
Oct-04-23 02:10PM
08:01AM
Sep-27-23 01:43PM
08:01AM
Sep-22-23 02:51PM
Sep-20-23 03:01AM
Sep-13-23 02:31PM
03:01AM
Sep-05-23 02:06PM
03:01AM
Aug-29-23 03:01AM
Aug-22-23 03:01AM
Aug-15-23 03:01AM
Aug-01-23 03:01AM
Jul-18-23 03:01AM
Jun-29-23 03:01AM
Jun-28-23 03:01AM
Jun-20-23 03:01AM
May-31-23 03:01AM
May-24-23 03:01AM
May-21-23 08:08AM
May-16-23 03:01AM
May-10-23 03:01AM
May-03-23 03:01AM
May-01-23 03:01AM
Apr-27-23 03:01AM
Apr-26-23 03:01AM
Apr-10-23 03:01AM
Apr-04-23 03:01AM
Mar-29-23 03:01AM
Mar-21-23 03:01AM
Mar-20-23 02:00PM
Mar-15-23 03:01AM
Mar-08-23 03:01AM
Mar-01-23 03:01AM
Feb-28-23 08:01AM
Feb-21-23 03:01AM
Mainz Biomed NV is a molecular genetics cancer diagnostic company. The firm is engaged in the developing of market-ready molecular genetic diagnostic solutions for life-threatening conditions. It is involved in the commercializing of its product portfolio in Europe, the United States, and the rest of world. The company was founded on March 08, 2021 and is headquartered in Mainz, Germany.